Cargando…

Lack of Association Between 25-Hydroxyvitamin D Level and Outcomes in Hospitalized Indian Patients With COVID-19

Vitamin D deficiency (VDD) is thought to play a role in determining the outcomes of COVID-19. India has a high prevalence of VDD. We hypothesized that VDD as measured by serum 25-hydroxyvitamin D (25OHD) <20 ng/mL is associated with severe COVID-19 infection. Outcomes were assessed by the WHO ord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jevalikar, Ganesh, Sharma, Rutuja, Farooqui, Khalid J, Singh, Anshu, Budhiraja, Sandeep, Dewan, Arun, Mithal, Ambrish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089673/ http://dx.doi.org/10.1210/jendso/bvab048.563

Ejemplares similares

Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
por: Jevalikar, Ganesh, et al.
Publicado: (2021)

High Prevalence of Diabetes in Hospitalized Patients With COVID-19 and Its Association With Greater Severity of COVID-19 in Delhi, India
por: Mithal, Ambrish, et al.
Publicado: (2021)

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes
por: Mithal, Ambrish, et al.
Publicado: (2021)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19
por: Dutta, Aditya, et al.
Publicado: (2021)

LBSAT229 Extended-release Calcifediol Effectively Raised 25-hydroxyvitamin D In CKD Despite Obesity
por: Strugnell, Stephen A, et al.
Publicado: (2022)

A Comparison of Free and Total 25-hydroxyvitamin D Levels as Functional Indicators of Bone Health in Healthy Children
por: Heo, You Joung, et al.
Publicado: (2021)

Oleanolic Acid Modulates 25-Hydroxyvitamin D(3) 1-alpha-hydroxylase in Osteoblasts and Human Mesenchymal Stem Cells
por: Yu, Wen-Xuan, et al.
Publicado: (2021)

ODP096 Hypercalcemia Secondary to Vitamin D Supplementation with Normal 25-Hydroxyvitamin D Level in an Elderly Female - Case Report
por: Arora, Gunjan, et al.
Publicado: (2022)

LBODP016 Lithocholic Acid Induced 25-hydroxyvitamin D-1alpha Hydroxylase (cyp27b1) Expression And Activities In Vitro And In Vivo
por: Lam, Chung Yan, et al.
Publicado: (2022)

SAT-514 The Decrease in Serum Parathyroid Hormone on Vitamin D Treatment Is Similar When Comparing Increases in Serum Free or Total 25 Hydroxyvitamin D in White and Black Women
por: Smith, Lynette, et al.
Publicado: (2019)

Video Consultation Versus In-Person Clinic Visit for Glycemic Control in Type 2 Diabetes during COVID-19 Pandemic (VIP-CD Study)
por: Dutta, Aditya, et al.
Publicado: (2021)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

OR01-3 Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum
por: Pantalone, Kevin, et al.
Publicado: (2022)

MON-515 Lack Of Association Between Bone Mineral Density And Breast Arterial Calcification: The Minerva Study
por: Iribarren, Carlos, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

SUN-LB086 Hypercalcemia in Metastatic Cholangiocarcinoma Due to Coexisting Elevated Parathyroid Hormone Related Protein (PTHrP) and 1,25-Dihydroxy Vitamin D (Calcitriol): A Case Report
por: Sharma, Rajeev
Publicado: (2019)

Total, Free and Bioavailble 25 OH D and Bone Disease in Primary Hyperparathyroidism
por: Santos, Lívia Marcela, et al.
Publicado: (2021)

SAT-356 Reversible Suppression of Serum 1,25-Dihydroxyvitamin D in Williams Syndrome
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

SAT246 Ectopic (Penile) Calcification in 1, 25 Vitamin D Induced Hypercalcemia
por: Berquist, John, et al.
Publicado: (2023)

MON-388 Total and Free 1,25dihydroxyvitamin D Levels in Postmenopausal Patients with Primary Hyperparathyroidism
por: Meng, Lingqiong, et al.
Publicado: (2020)

1-25OH(2)D Mediated Hypercalcemia Secondary to DISR From Immune Checkpoint Inhibitors
por: Disanti, Domenic, et al.
Publicado: (2021)

Appropriate Cutoff for 25OHD Levels in the Diagnosis of Normocalcemic Primary Hyperparathyroidism (NPHPT): A Systematic Review
por: Yedla, Niharika, et al.
Publicado: (2021)

LBSAT131 Extended-release Calcifediol Reduced Ipth And Normalized 1,25-dihydroxyvitamin D In Esrd.
por: Ashfaq, Akhtar, et al.
Publicado: (2022)

SAT240 Recurrent Hypercalcemia Due To 1,25 Dihydroxy Vitamin D Elevation Of Unclear Etiology
por: Javvaji, Abhiram, et al.
Publicado: (2023)

SAT-531 Low 25-OH-Vitamin D Levels in Women Observed before Initiating Osteoporosis Therapy
por: Li, Christina, et al.
Publicado: (2019)

ODP079 BCG-Osis, a Rare Cause of 1,25 Hydroxy Vitamin D Mediated Hypercalcemia
por: Azim, Sidra, et al.
Publicado: (2022)

ODP109 PARATHYROID HORMONE AND 25 OH VITAMINA D IN PREGNANCY: DATA FROM AN ARGENTINEAN COHORT SUPPORTING SUPPLEMENTATION.
por: Torres, Marta Isabel, et al.
Publicado: (2022)

PSAT198 Atypical Parathyroid Adenoma is an Unusual Cause of Primary Hyperparathyroidism
por: Limon, Makarem, et al.
Publicado: (2022)

PSAT167 Asian-Indians With Symptomatic Primary Hyperparathyroidism Have Lower Body Weight At Presentation And Tend To Gain Weight Post-Curative Parathyroidectomy
por: Pal, Rimesh, et al.
Publicado: (2022)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023)

SAT176 Comparison Of Prevalence For Normocalcemic Primary Hyperparathyroidism (NPHPT) Using Different 25(OH)D Levels: A Systematic Review
por: Farooqi, Iqra N, et al.
Publicado: (2023)

Therapeutic Potentials of Dimeric (Cys25)PTH(1–34) Peptide for Osteoporosis and Fracture Healing of the Bones- Buy One, Get One Free
por: Park, Doori, et al.
Publicado: (2021)

ODP129 Variation in 25(OH)D Levels, Measurement Methods and Prevalence of Vitamin D Deficiency: a Systematic Review and Meta-analysis
por: Premaor, Melissa, et al.
Publicado: (2022)

SAT-498 Use of Cinacalcet for PTHrP-Mediated Hypercalcemia of Malignancy in Penile Squamous Cell Carcinoma
por: Pulipati, Vishnu Priya, et al.
Publicado: (2019)

SAT180 Comparison Between Sporadic Primary Hyperparathyroidism And Multiple Endocrine Neoplasia Type 1 (MEN1)-Associated Primary Hyperparathyroidism: A Retrospective Analysis Of The Indian PHPT Registry
por: Bhadada, Sanjay, et al.
Publicado: (2023)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

SAT254 Elevated Vitamin D 1,25-Dioh Leading To The Diagnosis Of Diffuse Large B-cell Lymphoma With Excessive Vitamin D Intake Confounding The Clinical Picture
por: Barai, Rakhee, et al.
Publicado: (2023)

PSAT173 Weekly Supplementation with Vitamin D3 reduces 1,25(OH)2 vitamin D3 Measured by Mass Spectrometry, and increases Fibroblast-like growth factor 23 (FGF23) in Individuals with and without Primary Hyperparathyroidism (PHPT)
por: Sidana, Shivani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2nt89idbkpdho7nt89jfiqnogf